Case Study: Leading Pharmaceutical Company achieves high-quality, compliant eCOA data across multi-indication oncology studies with Clario

High-quality compliant eCOA data captured across group of oncology studies

Leading Pharmaceutical Company engaged Clario to provide an eCOA solution for a multi-indication oncology program that spanned 200 sites in 30 countries and ~2,500 patients. The sponsor needed a customizable, site-based system to enroll patients, collect QoL assessments (EQ-5D, QLQ-C30, FACT-P) on tablets, and deliver engaging training so sites could capture timely, accurate endpoint data.

Clario deployed its eCOA platform on provisioned tablets with integrated secure online enrollment, animated patient training, and real-time reporting. The solution delivered high-quality, compliant data across multiple studies, cost-effectively integrated assessments, and gave the sponsor real-time access to data for faster decision-making while supporting a validated QoL assessment library.